• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XU Hongjiang, SHI Wei, SONG Wei, ZHANG Ying, ZHAO Kaidi, ZHANG Yinsheng, YANG Ling, WANG Jinan. Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model[J]. Journal of China Pharmaceutical University, 2019, 50(4): 475-480. DOI: 10.11665/j.issn.1000-5048.20190413
Citation: XU Hongjiang, SHI Wei, SONG Wei, ZHANG Ying, ZHAO Kaidi, ZHANG Yinsheng, YANG Ling, WANG Jinan. Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model[J]. Journal of China Pharmaceutical University, 2019, 50(4): 475-480. DOI: 10.11665/j.issn.1000-5048.20190413
shu

Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model

More Information
    Graphical Abstract
    • Abstract
  • This study aims to discuss the therapeutic effect of magnesium isoglycyrrhizinate on hepatitis B virus(HBV)transgenic mouse and its effect on cellular immunity and liver inflammation. The changes of serum aspartate aminotransferase(AST)and alanine aminotransferase(ALT)activity, the difference of serum hepatitis B surface antigen(HBsAg), liver tissue HBsAg mRNA, and the pathological morphological changes of liver tissue were detected to investigate the hepatic inflammatory lesions and the efficacy of magnesium isoglycyrrhizinate in HBV transgenic mouse. Peripheral blood lymphocytes were classified by flow cytometry, and serum cytokines were detected by cytometric bead array(CBA)to explore the mechanism of magnesium isoglycyrrhizinate to reduce hepatic inflammatory lesions in HBV transgenic mouse. After grouping HBV transgenic mouse with serum transaminase activity and 35 days of continuous administration, serum transaminases level in magnesium isoglycyrrhizinate ［15 mg/(kg ·d)］ group was significantly lower than that in control group(P< 0. 05), serum HBsAg protein and liver tissue HBsAg mRNA increased with time, but there was no significant difference between the two groups. The main pathological changes of liver were liver cell swelling, necrosis and focal inflammatory cell infiltration, and the pathological changes of liver in magnesium isoglycyrrhizinate group were lighter than those in control group. The number of CD8+ cells in the blood of magnesium isoglycyrrhizinate group was significantly less than that in the control group(P< 0. 05)and the CD4+/CD8+ cell ratio was significantly higher than that in the control group(P< 0. 05). The content of inflammatory cytokines in serum of magnesium isoglycyrrhizinate group decreased significantly(P< 0. 05). Magnesium isoglycyrrhizinate can regulate the immune function of HBV transgenic mouse, decrease the infiltration of inflammatory cells in hepatic tissue and hepatocyte injury, but do not affect the expression of hepatocyte HBsAg.
    • FullText(HTML)
    • References (14)
  • [1]
    Xie C,Li X,Zhu J,et al.Magnesium isoglycyrrhizinate suppresses LPS-induced inflammation and oxidative stress through inhibiting NF-κB and MAPK pathways in RAW264.7 cells[J].Bioorg Med Chem,2019,27(3):516-524.
    [2]
    Ma D,Zhang J,Zhang Y,et al.Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice[J].Int Immunopharmacol,2018,55:237-244.
    [3]
    Ou MH.Pharmacology and clinical research progress of magnesium isoglycyrrhizinate[J].China Pharm(中国药业),2010,19(15):83-85.
    [4]
    Guo WN,Zhu B,Ai L,et al.Animal models for the study of hepatitis B virus infection[J].Zool Res,2018,39(1):25-31.
    [5]
    Dupinay T,Gheit T,Roques P,et al.Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from Mauritius Island[J].Hepatol,2013,58(5):1610-1620.
    [6]
    Dandri M,Volz TK,Lütgehetmann M,et al.Animal models for the study of HBV replication and its variants[J].J Clin Virol,2005,34(Suppl 1):S54-S62.
    [7]
    Chisari FV,Pinkert CA,Milich DR,et al.A transgenic mouse model of the chronic hepatitis B surface antigen carrier state[J].Science,1985,230(4730):1157-1160.
    [8]
    Babinet C,Farza H,Morello D,et al.Specific expression of hepatitis B surface antigen(HBsAg)in transgenic mouse[J].Science,1985,230(4730):1160-1163.
    [9]
    Guidotti L G,Matzke B,Schaller H,et al.High-level hepatitis B virus replication in transgenic mouse[J].J Virol,1995,69(10):6158-6169.
    [10]
    Kang AJ,Dong YH,Tian F,et al.Pathologic observation on C57BL/6J-HBV transgenic mouse[J].Chin J Lab Anim Sci(中国实验动物学杂志),2002,12(1):8-10.
    [11]
    Huang LR,Wu HL,Chen PJ,et al.An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection[J].Proc Natl Acad Sci,2006,103(47):17862-17867.
    [12]
    Huang YH,Fang CC,Tsuneyama K,et al.A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery[J].Int J Oncol,2011,39(6):1511-1519.
    [13]
    Dembek C,Protzer U.Mouse models for therapeutic vaccination against hepatitis B virus[J].Med Microbiol Immunol,2015,204(1):95-102.
    [14]
    Zheng DM,Guo YH,Zheng F.Flow cytometry analysis of intrahepatic lymphocyte subsets in chronic hepatitis B[J].J Mod Med Health(现代医药卫生),2012,28(1):102-104.
    • Related Articles

  • Related Articles

    [1]SHANG Feiyang, LIU Chengbo, TAN Hongzhou, HE Bing, HE Liqin. Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives[J]. Journal of China Pharmaceutical University, 2024, 55(3): 367-374. DOI: 10.11665/j.issn.1000-5048.2023072901
    [2]HU Yuheng, SUN Jie, YANG Jie, WANG Xiaojing. Synthesis and in vitro hypoglycemic activity of 3-(4′-benzoyl amino-phenyl)-coumarin derivatives[J]. Journal of China Pharmaceutical University, 2019, 50(2): 168-174. DOI: 10.11665/j.issn.1000-5048.20190206
    [3]YANG Guoxun, XIONG Juan, HU Jinfeng. 2017′s advanced natural products chemistry researches in China(2)[J]. Journal of China Pharmaceutical University, 2018, 49(6): 637-645. DOI: 10.11665/j.issn.1000-5048.20180601
    [4]YANG Guoxun, XIONG Juan, HU Jinfeng. 2017′s advanced natural products chemistry researches in China(1)[J]. Journal of China Pharmaceutical University, 2018, 49(5): 511-520. DOI: 10.11665/j.issn.1000-5048.20180501
    [5]YANG Rui, ZHU Yi, WANG Yin, MA Wenqi, WANG Xin, HAN Xiqiong, LIU Naifeng. Recent progress in autophagy and vascular calcification[J]. Journal of China Pharmaceutical University, 2018, 49(4): 401-406. DOI: 10.11665/j.issn.1000-5048.20180403
    [6]JIN Yue, WU Xuri, CHEN Yijun. Applications of glycosyltransferases in the improvement of druggability of natural products[J]. Journal of China Pharmaceutical University, 2017, 48(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20170504
    [7]YU Sulan, YU Xiu, KOU Junping. Advances in the mechanism research of natural products against acute lung injury[J]. Journal of China Pharmaceutical University, 2016, 47(4): 397-403. DOI: 10.11665/j.issn.1000-5048.20160403
    [8]XIANG Min, ZHANG Yaqin, WU Pingping, GAO Zhenyu. Effect of block of AGEs-RAGE pathway on the migration of VSMCs[J]. Journal of China Pharmaceutical University, 2016, 47(2): 199-203. DOI: 10.11665/j.issn.1000-5048.20160212
    [10]YANG Ya-Bo, WANG Min, LIANG Yan, LIANG Jing-Yu. Transgalactosylation of Isotaxiresinol by[J]. Journal of China Pharmaceutical University, 2002, (6).

Catalog

    Get Citation
    PDF
    XML
    Article views (513) PDF downloads (772) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：292672

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return